FCPA & Anti-Corruption for the Life Sciences Industry
New York, NY 10036
Event summary
The 19th Annual FCPA & Anti-Corruption for the Life Sciences Industry conference is the premier event for legal and compliance professionals from pharmaceutical, medical device, contract research organization and biotechnology companies to connect, compare notes and expand their networks.
The 2024 program will stand apart – featuring practical, carefully researched content based on key findings from multiple conversations with life sciences anti-corruption players. Experts will probe only the most cutting-edge strategies and emerging trends.
Featured agenda item
Thursday, May 9, 2024 | 12:00 – 12:45 pm EDT
Voluntary Disclosures: Understanding ‘Prompt Reporting,’ Cooperation Credit, Remediation and When to Engage Outside Counsel
Cooley partner Daniel Grooms will speak on this panel.
For more information, please email Amanda Meier.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.